35151118|t|Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation.
35151118|a|The nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome plays an important role in microglia-mediated inflammation. Dysregulation of NLRP3 signaling results in microglial activation and triggers inflammatory responses contributing to the development of neurological disorders including ischemic stroke, schizophrenia, Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Inhibition of the NLRP3-linked inflammatory pathways reduces microglia-induced inflammation and is considered as a promising therapeutic approach for neuro-inflammatory diseases. In the present study, we report the development of AMS-17, a rationally-designed tertiary sulfonylurea compound for inhibition of inflammation in microglia. AMS-17 inhibited expression of the NLRP3, and its downstream components and cytokines such as caspase-1, tumor necrosis factor-alpha (TNF-alpha), IL-1beta and inducible nitric oxide synthase (iNOS). It also suppressed lipopolysaccharide (LPS)-induced N9 microglial cell phagocytosis in vitro and activation of the microglia in mouse brain in vivo. Together, these results provide promising evidences for the inhibitory effects of AMS-17 in inflammation. This proof-of-concept study provides a new chemical scaffold, designed with the aid of pharmacophore modeling, with NLRP3 inhibitory activity which can be further developed for the treatment of inflammation-associated neurological disorders.
35151118	10	15	NLRP3	Gene	216799
35151118	46	67	sulfonylurea compound	Chemical	MESH:D013453
35151118	97	109	inflammation	Disease	MESH:D007249
35151118	188	193	NLRP3	Gene	216799
35151118	254	266	inflammation	Disease	MESH:D007249
35151118	285	290	NLRP3	Gene	216799
35151118	347	359	inflammatory	Disease	MESH:D007249
35151118	405	427	neurological disorders	Disease	MESH:D009461
35151118	438	453	ischemic stroke	Disease	MESH:D002544
35151118	455	468	schizophrenia	Disease	MESH:D012559
35151118	470	489	Alzheimer's disease	Disease	MESH:D000544
35151118	491	493	AD	Disease	MESH:D000544
35151118	496	515	Parkinson's disease	Disease	MESH:D010300
35151118	517	519	PD	Disease	MESH:D010300
35151118	526	555	amyotrophic lateral sclerosis	Disease	MESH:D000690
35151118	557	560	ALS	Disease	MESH:D000690
35151118	581	586	NLRP3	Gene	216799
35151118	594	606	inflammatory	Disease	MESH:D007249
35151118	642	654	inflammation	Disease	MESH:D007249
35151118	713	740	neuro-inflammatory diseases	Disease	MESH:D007249
35151118	793	799	AMS-17	Chemical	-
35151118	832	853	sulfonylurea compound	Chemical	MESH:D013453
35151118	872	884	inflammation	Disease	MESH:D007249
35151118	899	905	AMS-17	Chemical	-
35151118	934	939	NLRP3	Gene	216799
35151118	993	1002	caspase-1	Gene	12362
35151118	1004	1031	tumor necrosis factor-alpha	Gene	21926
35151118	1033	1042	TNF-alpha	Gene	21926
35151118	1045	1053	IL-1beta	Gene	16176
35151118	1058	1089	inducible nitric oxide synthase	Gene	18126
35151118	1091	1095	iNOS	Gene	18126
35151118	1117	1135	lipopolysaccharide	Chemical	MESH:D008070
35151118	1137	1140	LPS	Chemical	MESH:D008070
35151118	1150	1152	N9	CellLine	CVCL:0452
35151118	1226	1231	mouse	Species	10090
35151118	1329	1335	AMS-17	Chemical	-
35151118	1339	1351	inflammation	Disease	MESH:D007249
35151118	1469	1474	NLRP3	Gene	216799
35151118	1547	1559	inflammation	Disease	MESH:D007249
35151118	1571	1593	neurological disorders	Disease	MESH:D009461
35151118	Association	MESH:D007249	216799
35151118	Association	MESH:D012559	216799
35151118	Association	216799	21926
35151118	Association	18126	216799
35151118	Association	MESH:D002544	216799
35151118	Negative_Correlation	MESH:D013453	216799
35151118	Association	MESH:D009461	216799
35151118	Association	MESH:D000544	216799
35151118	Association	MESH:D010300	216799
35151118	Negative_Correlation	MESH:D013453	MESH:D007249
35151118	Association	MESH:D000690	216799
35151118	Association	12362	216799
35151118	Positive_Correlation	16176	216799

